MEDS will publish its interim report for the third quarter of 2025 on November 7, 2025, at 07:30 CET. A webcast presentation will be held at: https://www.finwire.tv/webcast/meds-apotek/meds-2025/ for analysts, media, and investors at 10:00 CET the same day.

The report will be presented by Björn Thorngren, CEO and co-founder, and Nick Mendola, CFO.
The presentation will be conducted in English and broadcast live online. To register please email ir@meds.se at latest 09.00 CET on November 7, 2025. 

A recorded version of the presentation will also be available at: https://www.finwire.tv/webcast/meds-apotek/meds-2025/
 
Phone number for analysts: +46850163827, then enter the meeting ID: 81972913787 followed by #
 
Schedule on the 7th of November:

• 07:30 CET – Publication of the Q3 report
• 10:00 CET – Webcast and conference call with CEO Björn Thorngren and CFO Nick Mendola

 
For further information, please contact:
Frida Benno Hjerpe
MEDS Press & Investor Relations
E-mail: press@meds.se
Web: https://corporate.meds.se/

About MEDS
MEDS.se is a full-scale online pharmacy licensed by the Swedish Medical Products Agency. We provide both prescription and over-the-counter medicines for you, your family, and your pets.
In addition, MEDS offers a wide range of products in health, beauty, and wellness.

Certified advisor is FNCA.